What constitutes Diabetic Ketoacidosis (DKA)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 19, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Diabetic ketoacidosis (DKA) is a serious complication of diabetes characterized by hyperglycemia, ketosis, and metabolic acidosis, typically defined by blood glucose levels above 250 mg/dL, the presence of ketones in blood or urine, and a blood pH below 7.3 with a bicarbonate level less than 18 mEq/L, as stated in the most recent guidelines 1.

Definition and Diagnosis

DKA occurs when the body cannot use glucose for energy due to insufficient insulin, causing it to break down fat for fuel instead, which produces ketones that accumulate in the blood. The condition develops when insulin deficiency is combined with increased levels of counter-regulatory hormones like glucagon, cortisol, and catecholamines, which typically happens during illness, infection, or when insulin doses are missed 1.

Key Characteristics

Some key characteristics of DKA include:

  • Hyperglycemia
  • Ketosis
  • Metabolic acidosis
  • Blood glucose levels above 250 mg/dL
  • Presence of ketones in blood or urine
  • Blood pH below 7.3 with a bicarbonate level less than 18 mEq/L

Management and Treatment

Management goals for DKA include restoration of circulatory volume and tissue perfusion, resolution of hyperglycemia, and correction of electrolyte imbalance and acidosis, with treatment focusing on fluid replacement, insulin therapy, and electrolyte correction to address the underlying metabolic derangements 1.

Recent Guidelines

According to the most recent guidelines, there is no significant difference in outcomes for intravenous human regular insulin versus subcutaneous rapid-acting analogs when combined with aggressive fluid management for treating mild or moderate DKA, and the use of bicarbonate in patients with DKA is generally not recommended 1.

From the FDA Drug Label

Hyperglycemia (too much glucose in the blood) may develop if your body has too little insulin. Hyperglycemia can be brought about by any of the following: Omitting your insulin or taking less than your doctor has prescribed. In patients with type 1 or insulin-dependent diabetes, prolonged hyperglycemia can result in DKA (a life-threatening emergency) The first symptoms of DKA usually come on gradually, over a period of hours or days, and include a drowsy feeling, flushed face, thirst, loss of appetite, and fruity odor on the breath. With DKA, blood and urine tests show large amounts of glucose and ketones.

Diabetic Ketoacidosis (DKA) is constituted by:

  • Prolonged hyperglycemia
  • Presence of ketones in the blood and urine
  • Symptoms such as:
    • Drowsy feeling
    • Flushed face
    • Thirst
    • Loss of appetite
    • Fruity odor on the breath
    • Heavy breathing
    • Rapid pulse 2 2

From the Research

Definition of Diabetic Ketoacidosis (DKA)

Diabetic ketoacidosis (DKA) is a serious complication of diabetes that occurs when the body produces high levels of blood acids called ketones. The condition is characterized by:

  • Hyperglycemia (high blood sugar levels) [ 3, 4, 5, 6 ]
  • Ketosis (presence of ketones in the blood or urine) [ 3, 7, 4, 5, 6 ]
  • Metabolic acidosis (high anion gap acidosis) [ 3, 7, 4, 5, 6 ]

Diagnostic Criteria

A diagnosis of DKA is confirmed when all three of the following criteria are present:

  • 'D': elevated blood glucose levels or a family history of diabetes mellitus [ 3 ]
  • 'K': presence of high urinary or blood ketoacids [ 3 ]
  • 'A': high anion gap metabolic acidosis [ 3 ]

Special Considerations

DKA can also occur in patients with euglycemia (normal blood sugar levels) [ 7 ] and can be masked by other metabolic derangements, such as primary metabolic alkalosis [ 7 ].

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Diabetic ketoacidosis.

Nature reviews. Disease primers, 2020

Research

Management of Diabetic Ketoacidosis in Adults: A Narrative Review.

Saudi journal of medicine & medical sciences, 2020

Research

Diabetic ketoacidosis.

Disease-a-month : DM, 2023

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.